Currently David Galan is the Director of FLUIDNATEK, the brand under which Bioinicia commercializes its electrospinning and electrospraying equipment. David has a MS in Mechanical Engineering from Sevilla University, a MPhil from Malaga University in the field of electro-hydrodynamic atomization (PhD thesis defense pending), and a Master in Business Administration from San Telmo Institute. Since he completed his Engineering Master, David has been linked to the electro-hydrodynamic technology, always from the company perspective. He is specialized in high-throughput electrospinning and electrospraying systems for volume production of nanoparticles and nanofibers. He has 2 scientific articles and over 30 conference contributions.


Due to its flexibility and versatility, electrohydrodynamic processing comprising electrospinning and electrospraying, has emerged as an interesting technology to produce micron, submicron and nanostructured fiber mats and powdered materials from natural and/or synthetic polymers. Co-axial and multi-axial structures, produced by concentric needles or other spinning devices, are of great interest in many fields of application and this paper will review some of the most significant to which our company scientists have strongly contributed over the last years. Despite the enormous potential of this technology, it still remains at a laboratory scale due to the limited yielding and flexibility provided by most commercial tools. The Fluidnatek brand of Bioinicia S.L. (Valencia, Spain) gathers a group of engineers with more than 15 years of experience in electrospinning and electrospraying engineering and applications. Bioinicia S.L. has rebranded the technology to provide flexible, secured, rock solid and affordable tailor made tools, i.e. from the lab LE10 model to the ambitious LE1000 industrial model, to solve most problems that researchers and industrialists may face everyday for the execution and scaling up of their experiments and products. Fluidnatek pilot plant and industrial systems are the state of the art in the current high throughput electrohydrodynamic commercial panorama, providing efficient mass production solutions to scale up any lab development while meeting the quality standards required by industry. This paper will also highlight some recent advances carried out with Bioinicia's technology in which highly functional biopolymers and nanobiocomposites has been developed for regenerative medicine.